4.7 Article

PNPLA3 Genotype, Arachidonic Acid Intake, and Unsaturated Fat Intake Influences Liver Fibrosis in Hispanic Youth with Obesity

Journal

NUTRIENTS
Volume 13, Issue 5, Pages -

Publisher

MDPI
DOI: 10.3390/nu13051621

Keywords

non-alcoholic fatty liver disease; liver stiffness; fibrosis; PNPLA3; genotype; arachidonic acid; unsaturated fat

Funding

  1. L.K. Whittier Foundation [003457-00001]
  2. NIH/NIMHD [R01 MD010358]
  3. Department of Education of the Basque Government [EP_2019_1_0013]

Ask authors/readers for more resources

This study found that arachidonic acid intake is associated with liver fibrosis, while reducing intake of polyunsaturated fatty acids might be important for preventing non-alcoholic fatty liver disease progression, especially among individuals with PNPLA3 risk alleles. Sex, genotype, and liver fat can affect the association between dietary types and liver fibrosis.
Non-alcoholic fatty liver disease impacts 15.2% of Hispanic adolescents and can progress to a build-up of scared tissue called liver fibrosis. If diagnosed early, liver fibrosis may be reversible, so it is necessary to understand risk factors. The aims of this study in 59 Hispanic adolescents with obesity were to: (1) identify potential biological predictors of liver fibrosis and dietary components that influence liver fibrosis, and (2) determine if the association between dietary components and liver fibrosis differs by PNPLA3 genotype, which is highly prevalent in Hispanic adolescents and associated with elevated liver fat. We examined liver fat and fibrosis, genotyped for PNPLA3 gene, and assessed diet via 24-h diet recalls. The prevalence of increased fibrosis was 20.9% greater in males, whereas participants with the GG genotype showed 23.7% greater prevalence. Arachidonic acid was associated with liver fibrosis after accounting for sex, genotype, and liver fat (beta = 0.072, p = 0.033). Intakes of several dietary types of unsaturated fat have different associations with liver fibrosis by PNPLA3 genotype after accounting for sex, caloric intake, and liver fat. These included monounsaturated fat (beta(CC/CG) = -0.0007, beta(GG) = 0.03, p-value = 0.004), polyunsaturated fat (beta(CC/CG) = -0.01, beta(GG) = 0.02, p-value = 0.01), and omega-6 (beta(CC/CG) = -0.0102, beta(GG) = 0.028, p-value = 0.01). Results from this study suggest that reduction of arachidonic acid and polyunsaturated fatty acid intake might be important for the prevention of non-alcoholic fatty liver disease progression, especially among those with PNPLA3 risk alleles.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available